Stock RBOT VICARIOUS SURGICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Vicarious Surgical Inc.

Equities

RBOT

US92561V1098

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.2806 USD +0.21% Intraday chart for Vicarious Surgical Inc. -1.06% -23.48%
Apr. 29 Transcript : Vicarious Surgical Inc., Q1 2024 Earnings Call, Apr 29, 2024
Apr. 29 Vicarious Surgical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Vicarious Surgical Inc.

Price target over the last 5 years

History of analyst recommendation changes

3e1c8.pCAEMlwovyArYDqnf7gEcWxDegFzsWO556FTxiMaQEA.9HB-dC8Q3BZALwzgD-dKLlQAM1RBiRv6qPkLrGdrNi3qTmlRJEnsf29Waw~620f25be0579473c6ba8b5ff3a39b94f

Analyst Recommendations on Vicarious Surgical Inc.

Piper Sandler Adjusts Price Target on Vicarious Surgical to $1 From $1.50, Keeps Neutral Rating MT
Morgan Stanley Initiates Vicarious Surgical With Equalweight Rating, Price Target is $0.60 MT
BTIG Research Downgrades Vicarious Surgical to Neutral From Buy MT
Canaccord Genuity Adjusts Vicarious Surgical's Price Target to $9 From $12, Keeps Buy Rating MT
BTIG Adjusts Vicarious Surgical's Price Target to $7 From $8, Maintains Buy Rating MT
Piper Sandler Adjusts Vicarious Surgical's Price Target to $5 From $7, Maintains Neutral Rating MT
Credit Suisse Lowers Price Target for Vicarious Surgical to $13 From $16, Maintains Outperform Rating MT
Canaccord Genuity Adjusts Vicarious Surgical's Price Target to $13 From $15, Maintains Buy Rating MT
Piper Sandler Downgrades Vicarious Surgical to Neutral From Overweight, Adjusts Price Target to $7 From $16 MT
Credit Suisse Initiates Vicarious Surgical at Outperform with $16 Price Target MT
Credit Suisse Starts Vicarious Surgical at Outperform with $16 PT, Says Next-Gen Robotic Surgery Platform Set to Potentially Disrupt, Expand Market MT
Cowen Starts Vicarious Surgical at Outperform With $15 Price Target MT
Canaccord Genuity Initiates Coverage on Vicarious Surgical With Buy Rating, $15 Price Target MT
VICARIOUS SURGICAL : BTIG Initiates Vicarious Surgical at Buy Rating With $15 Price Target MT
VICARIOUS SURGICAL : Piper Sandler Starts Vicarious Surgical at Overweight With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.2806 USD
Average target price
1.033 USD
Spread / Average Target
+268.26%
High Price Target
1.5 USD
Spread / Highest target
+434.57%
Low Price Target
0.6 USD
Spread / Lowest Target
+113.83%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vicarious Surgical Inc.

Piper Sandler
Morgan Stanley
BTIG
Canaccord Genuity
Credit Suisse
Cowen

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RBOT Stock
  4. Consensus Vicarious Surgical Inc.